The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

Google DeepMind CEO Demis Hassabis, one of the only people in the world with a Nobel Prize for work on artificial ...

As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing over the years due to the growing demand for personalized medicine, the ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

At Google DeepMind, researchers are chasing what's called artificial general intelligence: a silicon intellect as versatile ...

Hassabis pointed out the potential of AI to transform medicine by significantly lessening the time and expense of drug ...

Google DeepMind CEO, Demis Hassabis, a Nobel laureate, envisions AI revolutionizing healthcare, potentially curing all ...

Clinical trials are vital to drug development but often face challenges such as slow patient recruitment, high costs, and suboptimal trial designs. Today, artificial intelligence (AI) and real ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

Nobel laureate and DeepMind CEO Demis Hassabis envisions a future where AI revolutionizes healthcare by drastically accelerating drug development—from years to weeks—and potentially curing all ...